As a healthcare technology company, IMNA Solutions is hyperaware of the severity of coronavirus, and we’re working to put a stop to it. We’re currently teaming up with researchers and pharmaceutical companies to help bring a COVID-19 vaccine to market by providing free access to our clinical trial data collection, patient engagement and management software.
Right now, our software is being used by three chief resource officers to accelerate these efforts, but we would love to give it to as many research teams as possible. Coronavirus has thus far affected more than 118,000 people and killed at least 4,200 across the world, and enough is enough.
Meirav Naor-Weinstock is co-founder and CEO of IMNA Solutions.
